Targeted Therapy: Wave of the Future
Author:
Affiliation:
1. From the Division of Hematology/Oncology, Department of Medicine, David Geffen/UCLA School of Medicine at Los Angeles; and Genentech Inc, South San Francisco, CA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.11.029
Reference26 articles.
1. The Genetic Origins of Neoplasia
2. Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms
3. Recent advances in breast cancer biology
4. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
5. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection ofcyclin D1 in breast andcyclin E in ovarian tumors
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology;American Society of Clinical Oncology Educational Book;2020-05
2. New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified;Journal of Cancer Research and Clinical Oncology;2020-02-08
3. Herceptin;Encyclopedia of Cancer;2017
4. New oral targeted therapies for metastatic breast cancer disrupt the traditional patients’ management-A healthcare providers’ view;European Journal of Cancer Care;2016-12-27
5. Herceptin;Encyclopedia of Cancer;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3